[Clinical evaluation of KPC by the double blind test against infection and postoperative inflammation in oral surgery (author's transl)]. 1976

T Ishikawa, and Y Watanabe, and N Morisawa, and A Tanaka, and H Inui

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009055 Mouth The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper. Oral Cavity,Cavitas Oris,Cavitas oris propria,Mouth Cavity Proper,Oral Cavity Proper,Vestibule Oris,Vestibule of the Mouth,Cavity, Oral
D010447 Peptide Hydrolases Hydrolases that specifically cleave the peptide bonds found in PROTEINS and PEPTIDES. Examples of sub-subclasses for this group include EXOPEPTIDASES and ENDOPEPTIDASES. Peptidase,Peptidases,Peptide Hydrolase,Protease,Proteases,Proteinase,Proteinases,Proteolytic Enzyme,Proteolytic Enzymes,Esteroproteases,Enzyme, Proteolytic,Hydrolase, Peptide
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011402 Pronase A proteolytic enzyme obtained from Streptomyces griseus. Pronase E,Pronase P,Protease XIV,XIV, Protease
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic

Related Publications

T Ishikawa, and Y Watanabe, and N Morisawa, and A Tanaka, and H Inui
January 1975, Nihon Koku Geka Gakkai zasshi,
T Ishikawa, and Y Watanabe, and N Morisawa, and A Tanaka, and H Inui
January 1974, Nihon Koku Geka Gakkai zasshi,
T Ishikawa, and Y Watanabe, and N Morisawa, and A Tanaka, and H Inui
January 1974, Nihon Koku Geka Gakkai zasshi,
T Ishikawa, and Y Watanabe, and N Morisawa, and A Tanaka, and H Inui
January 1976, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Ishikawa, and Y Watanabe, and N Morisawa, and A Tanaka, and H Inui
January 1974, Nihon Koku Geka Gakkai zasshi,
T Ishikawa, and Y Watanabe, and N Morisawa, and A Tanaka, and H Inui
January 1988, Stoma (Lisbon, Portugal),
T Ishikawa, and Y Watanabe, and N Morisawa, and A Tanaka, and H Inui
January 1973, Nihon Koku Geka Gakkai zasshi,
T Ishikawa, and Y Watanabe, and N Morisawa, and A Tanaka, and H Inui
January 1974, Nihon Koku Geka Gakkai zasshi,
T Ishikawa, and Y Watanabe, and N Morisawa, and A Tanaka, and H Inui
January 1983, European journal of rheumatology and inflammation,
T Ishikawa, and Y Watanabe, and N Morisawa, and A Tanaka, and H Inui
August 1979, Ryumachi. [Rheumatism],
Copied contents to your clipboard!